Skip to main content

Case Studies in Opioid Decontamination and Cleanup (AIHce EXP 2019 OnDemand)

Course Description:
Recorded at AIHce EXP 2019


Sampling and Analysis of Residual Synthetic Opioid Contamination in Uncontrolled Environments for the Assessment/Control of Risk and to Demonstrate Cleaning Efficacy

On average, 115 Americans die every day from an opioid overdose. In 2013, there were significant increases in overdose deaths involving synthetic opioids involving illicitly-manufactured fentanyl (IMF) and fentanyl analogs. The IMF market continues to change and IMF can be found in combination with heroin, counterfeit pills, and cocaine. This is a presentation on the testing (sampling and analysis) for highly potent drug residuals such as Fentanyl and Fentanyl analogs in unregulated and uncontrolled environments (e.g., illicit drug labs, remediation sites, law enforcement evidence handling and storage facilities). The presentation will include an overview of the purposes for testing, available tests/technologies, sampling strategies and interpretation of results.

Co-Authors / Acknowledgements & References
Maxxam Anayltes, Bureau Veritas, Lake Zurich, IL, USA.

Matthew Meiners, CIH, BV/Maxxam Pharmaceutical IH Laboratory Lake Zurich, IL
United States of America

After the First Responders Leave – The Assessment and Cleanup of an Opioid Contaminated Residence
From 1999-2016, more than 350,000 people have died from an overdose involving opioids (prescription and illicit). In 2013, there were significant increases in overdose deaths involving synthetic opioids involving illicitly-manufactured fentanyl (IMF) and fentanyl analogs. Illicit activities resulting in latent contamination of highly potent opioids (fentanyl and derivatives) are increasing rapidly, creating risks to law enforcement, first responders and remediation contractors. This case study depicts a representative situation where the illicit shipment receipt, handling, processing, and distribution of fentanyl- based products was performed in a residence. Significant levels of surface contamination were identified as a result. Although such levels of contaminants is considered highly toxic, such cases fall outside the regulatory authority of local health departments and regulatory oversight in most cases.

Co-Authors / Acknowledgements & References
BioMax Environmental, Inc., Pacific Grove, CA, USA. San Francisco Department of Public Health, San Francisco, CA, USA.

Michael Polkabla, CIH, REA, BioMax Environmental, Inc Pacific Grove, CA
United States of America

Decontamination Options for Fentanyl-contaminated Materials
This presentation will provide an overview of EPA's role in a fentanyl response and will contain the results from research that was initiated to fill select gaps identified during the development of EPA's Fact Sheet for OSCs: Fentanyl and Fentanyl Analogs (Fentanyl Fact Sheet). Results from surface decontamination tests will be presented. These tests included multiple decontamination solutions that are identified in the Fentanyl Fact Sheet as well as more recently identified decontaminants of interest. Decontamination efficacy data are derived from a spray application of the decontaminant to nonporous materials contaminated with a solid fentanyl salt.

Co-Authors / Acknowledgements & References

U.S. Environmental Protection Agency, Office of Research and Development, National Homeland Security Research Center, Research Triangle Park, NC USA. Presented by John Archer, EPA.

Lukas Oudejans, Ph.D, U.S. Environmental Protection Agency, Office of Research and Development Research Triangle Park, NC

United States of America

Contact Hours:

Presentation Date: